insights_auto
Why is ERNA up 4.18%?
Dive Deeperchevron_right
ERNA:NASDAQ
Ernexa Therapeutics Inc
$2.49
arrow_upward
+4.18%(+0.100) 1D
$2.50
arrow_upward
+0.40% (+0.0100)bedtimeAfter hours
Closed: Oct 8, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ERNA...
Open
$2.40
High
$2.70
Low
$2.12
Mkt. cap
4.06M
Avg. vol.
65.05K
Volume
213.74K
52-wk high
$71.50
52-wk low
$2.12
EPS
-$18.69
Beta
2.64
Shares outstanding
1.63M
No. of employees
5
Open
$2.40
High
$2.70
Low
$2.12
Mkt. cap
4.06M
Avg. vol.
65.05K
Volume
213.74K
52-wk high
$71.50
52-wk low
$2.12
EPS
-$18.69
Beta
2.64
Shares outstanding
1.63M
No. of employees
5
News stories
From web sources and news partners
Stock Titan
·
2 days ago
In animal tests, cell therapy plus immune treatment fully controlled ovarian tumors in most animals.
GlobeNewswire
·
2 days ago
Ernexa Therapeutics’ ERNA-101 Selected for Flash Talk
Benzinga
·
2 days ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
About Ernexa Therapeutics Inc
CEO-
Employees5
Founded2018
HeadquartersBrooklyn, New York, United States
SectorBiotechnology
Websiteernexatx.com